Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T, Ohba K, Matsubara J, Maeda H, Horibata Y, Sakamoto K
increases hypoglycaemia risk when combined with insulin or sulfonylureas Cardiovascular health Emerging evidence suggests cardiovascular benefits associated with significant weight loss and improved metabolic markers Long-term cardiovascular outcome data for tirzepatide specifically is still accumulating compared with older GLP-1 agents Gastrointestinal side effects Typically mild to moderate and temporary, particularly during dose escalation
Why so thorough for what people assume is a quick prescription
H.pylori-infected duodenal ulcer patients are subjected to massive oxidative stress as reflected by a significant decrease of erythrocytic GPx and SOD activities and elevation of plasma MDA levels
Several B vitamins affect hair growth
About half of users stop GLP-1s shortly after treatment, due to the high cost of medications, uncomfortable side effects and age, researchers say